• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在胸腔积液中测定的三种肿瘤标志物的诊断价值。

Diagnostic value of three tumor markers determined in pleural effusions.

作者信息

Conejo J R, Benedito J E, Jimenez A, Menchen M, Cano J, Granizo V, Larrodera L

机构信息

Servicio de Analisis Clinicos, Hospital General Universitario de Guadalajara, Guadalajara, Spain.

出版信息

Eur J Clin Chem Clin Biochem. 1996 Feb;34(2):139-42.

PMID:8833646
Abstract

In order to discriminate between malignant and benign effusions, the values of tissue polypeptide specific antigen,carcinoembryonic antigen and squamous cell carcinoma associated antigen were measured in the pleural fluid of 30 patients with neoplasm, 10 with tuberculous pleurisy, 10 with transudates due to congestive heart failure or cirrhosis, 29 with parapneumonic effusions and 23 with benign diseases other than tuberculosis and pneumonia. Carcinoembryonic antigen and tissue poly-peptide specific antigen levels in effusions due to neoplasms were significantly higher than those in effusions due to other diseases. The areas under Receiver Operating Characteristic curves for carcinoembryonic antigen and tissue polypeptide specific antigen determinations were 0.69 and 0.67, respectively. No significant differences were found in the pleural fluid squamous cell carcinoma associated antigen levels between neoplasms and other diseases. The ability of tissue polypeptide specific antigen and carcinoembryonic antigen to discriminate between benign and malignant effusions may be considered comparable. Although both carcinoembryonic antigen and tissue polypeptide specific antigen showed a low accuracy (the number of undiagnosed pleural effusions is considerably high), both tissue polypeptide specific antigen and carcinoembryonic antigen determinations may contribute to a correct diagnostic classification. Moreover, the combination of these markers provides a specificity of 97.2%. However, the low number of positivities obtained for tissue polypeptide specific antigen and carcinoembryonic antigen together (13 cases in our series) reveals the need for further investigations.

摘要

为鉴别恶性和良性胸腔积液,对30例肿瘤患者、10例结核性胸膜炎患者、10例因充血性心力衰竭或肝硬化所致漏出液患者、29例类肺炎性胸腔积液患者以及23例除结核和肺炎以外的良性疾病患者的胸腔积液进行组织多肽特异性抗原、癌胚抗原和鳞状细胞癌相关抗原检测。肿瘤所致胸腔积液中的癌胚抗原和组织多肽特异性抗原水平显著高于其他疾病所致胸腔积液。癌胚抗原和组织多肽特异性抗原检测的受试者工作特征曲线下面积分别为0.69和0.67。肿瘤与其他疾病患者的胸腔积液鳞状细胞癌相关抗原水平无显著差异。组织多肽特异性抗原和癌胚抗原鉴别良性和恶性胸腔积液的能力可认为相当。尽管癌胚抗原和组织多肽特异性抗原的准确性均较低(未诊断出的胸腔积液数量相当多),但组织多肽特异性抗原和癌胚抗原检测均有助于正确的诊断分类。此外,这些标志物联合使用的特异性为97.2%。然而,组织多肽特异性抗原和癌胚抗原同时呈阳性的数量较少(本研究系列中有13例),这表明需要进一步研究。

相似文献

1
Diagnostic value of three tumor markers determined in pleural effusions.在胸腔积液中测定的三种肿瘤标志物的诊断价值。
Eur J Clin Chem Clin Biochem. 1996 Feb;34(2):139-42.
2
Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.癌抗原72-4、癌胚抗原、癌抗原15-3和癌抗原19-9检测在胸腔积液中的诊断价值。一项针对207例患者的研究。
Cancer. 1996 Aug 15;78(4):736-40. doi: 10.1002/(SICI)1097-0142(19960815)78:4<736::AID-CNCR7>3.0.CO;2-C.
3
[Clinical evaluation of various tumor markers in pleural effusion and in the serum].[胸腔积液与血清中多种肿瘤标志物的临床评估]
Gan No Rinsho. 1989 Aug;35(9):991-8.
4
[Diagnostic value of the tumor markers TPA-M, CYPFRA 21-1 and CEA in pleural effusion. Prospective comparison of thoracoscopic investigations in patients with pleural effusion].[肿瘤标志物TPA-M、CYPFRA 21-1和CEA在胸腔积液中的诊断价值。胸腔积液患者胸腔镜检查的前瞻性比较]
Pneumologie. 1999 Oct;53(10):471-6. doi: 10.1055/s-1999-9039.
5
Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions.肿瘤标志物组合在恶性胸腔积液诊断中的临床应用
Anticancer Res. 2008 Sep-Oct;28(5B):2947-52.
6
New approaches in the diagnostic procedure of malignant pleural effusions.恶性胸腔积液诊断程序中的新方法。
Oncol Rep. 2004 Jul;12(1):79-83.
7
[Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion].[癌胚抗原、神经元特异性烯醇化酶及鳞状细胞癌抗原在恶性胸腔积液中的诊断价值]
An Med Interna. 1996 Aug;13(8):369-73.
8
Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions.胸腔积液中的可溶性癌蛋白185HER-2在恶性胸腔积液的诊断评估中作用有限。
Clin Biochem. 2005 Nov;38(11):1031-3. doi: 10.1016/j.clinbiochem.2005.05.001. Epub 2005 May 31.
9
[Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].[酶免疫分析法联合检测胸腔积液和血清中癌胚抗原(CEA)的诊断价值。敏感性、特异性及与肿瘤类型的关系]
Wien Klin Wochenschr. 1986 Sep 12;98(17):564-73.
10
Diagnostic value of Her-2/neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma.Her-2/neu、Cyfra 21-1 和癌胚抗原水平在肺腺癌恶性胸腔积液中的诊断价值。
Pathology. 2010 Apr;42(3):224-8. doi: 10.3109/00313021003631320.